| 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 大豆油(口服)(元) | 7,322,830.88 | 10,310,900.32 | 4,263,263.50 |
| 大豆油(注射)(元) | 17,739,380.67 | 31,984,138.30 | 13,633,121.86 |
| 中链甘油三酸酯(元) | 31,523,745.07 | 52,028,991.10 | 28,092,663.70 |
| 其他(元) | - | 3,106,924.51 | - |
| 营业成本(元) | |||
| 大豆油(口服)(元) | 5,486,091.67 | 9,109,234.15 | 3,948,832.30 |
| 大豆油(注射)(元) | 6,930,158.15 | 14,394,159.68 | 6,215,187.27 |
| 中链甘油三酸酯(元) | 11,400,903.31 | 27,947,160.05 | 16,002,807.40 |
| 其他(元) | - | 3,832,083.53 | - |
| 毛利(元) | |||
| 大豆油(口服)(元) | 1,836,739.21 | 1,201,666.17 | 314,431.20 |
| 大豆油(注射)(元) | 10,809,222.52 | 17,589,978.62 | 7,417,934.59 |
| 中链甘油三酸酯(元) | 20,122,841.76 | 24,081,831.05 | 12,089,856.30 |
| 其他(元) | - | -725,159.02 | - |
| 毛利率(%) | |||
| 大豆油(口服)(%) | 25.08 | 11.65 | 7.38 |
| 大豆油(注射)(%) | 60.93 | 55.00 | 54.41 |
| 中链甘油三酸酯(%) | 63.83 | 46.29 | 43.04 |
| 其他(%) | - | -23.34 | - |
| 收入构成(%) | |||
| 大豆油(口服)(%) | 12.94 | 10.58 | 9.27 |
| 大豆油(注射)(%) | 31.35 | 32.83 | 29.64 |
| 中链甘油三酸酯(%) | 55.71 | 53.40 | 61.09 |
| 其他(%) | - | 3.19 | - |
| 毛利构成(%) | |||
| 大豆油(口服)(%) | 5.61 | 2.85 | 1.59 |
| 大豆油(注射)(%) | 32.99 | 41.73 | 37.42 |
| 中链甘油三酸酯(%) | 61.41 | 57.14 | 60.99 |
| 其他(%) | - | -1.72 | - |